PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsCelera revokes its promise on gene patents

BioNews

Celera revokes its promise on gene patents

Published 9 June 2009 posted in News and appears in BioNews 32

Author

BioNews

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A US biotechnology company is attempting to patent parts of the human genome in order to profit from its research before Human Genome Project - an alliance of government and charity-funded labs - move to ensure that sequenced genetic codes are made publicly and freely available on the Internet. The Maryland-based Celera...

A US biotechnology company is attempting to patent parts of the human genome in order to profit from its research before Human Genome Project - an alliance of government and charity-funded labs - move to ensure that sequenced genetic codes are made publicly and freely available on the Internet.


The Maryland-based Celera Genomics, set up by the gene sequencer Dr Craig Venter, has astonished the scientific community by claiming to have sequenced a third of the human genome (1.2 billion DNA bases) in just one month. He is predicting that Celera will be able to sequence the entire genome by next year - simultaneously or even ahead of the Human Genome Project. Last week, the company broke its earlier promise not to patent human genes by announcing its intention to patent about 6,500 pieces of genetic information. 'Celera's mission is to become the definitive source of genomic and related agricultural and medical information,' the company said, adding that use of its data would be available 'on a subscription basis' to universities and other companies. This comes as a blow to the British-led efforts to negotiate an Anglo-American deal to ban patents on genome research in order to help researchers gain free access to information that could lead to medical treatments.


Under the proposed deal, all laboratories participating in the Human Genome Project would have to waive their patents rights. The UK's Wellcome Trust and the US National Institutes of Health which are leading the project would publish the code of each gene within 24 hours of its sequencing. The US patents office said it has issued three patents so far and is considering up to 10,000 other applications. However, Dr Mike Dextor of the Wellcome Trust reiterated the Trust' commitment to legally challenging any patents which it considers invalid or so wide-ranging that they would restrict research by other groups.

Leave a Reply Cancel reply

You must be logged in to post a comment.

« British science slipping, says Glaxo chairman

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856